36 results on '"Álvares-da-Silva, Mário Reis"'
Search Results
2. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
3. Predicting liver fibrosis in Gaucher disease: Investigation of contributors and development of a clinically applicable Gaucher liver fibrosis score
4. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
5. Firmicutes/Bacteroidetes and Firmicutes/Proteobacteria ratios are associated with worse prognosis in a cohort of Latin American patients with cirrhosis
6. A global research priority agenda to advance public health responses to fatty liver disease
7. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats
8. Changes in the gut microbiota of rats after exposure to the fungicide Mancozeb
9. Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters
10. Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
11. New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
12. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease
13. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil
14. Assessing the impact of COVID-19 on liver cancer management (CERO-19)
15. Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil
16. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
17. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
18. Liver involvement in patients with Gaucher disease types I and III
19. O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA
20. O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
21. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study
22. Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases
23. O-21 EVIDENCE OF SUBOPTIMAL PUBLIC HEALTH POLICIES ON HEPATOCELLULAR CARCINOMA IN THE AMERICAS: A HUGE DEBT OF OUR REGION
24. Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste
25. Hepatotoxicity by methyl methacrylate
26. Hepatocellular carcinoma in Gaucher disease: Reinforcing the proposed guidelines
27. Protocol to segment and characterize the morphometry of individual cross-sectioned striated muscle fibers from adult murine models
28. OS063 - CLEARED Global consortium results highlight regional variation and need for equity in inpatient outcomes in hospitalized patients with Chronic Liver Disease
29. OS008 - Risk factors for short-term post discharge clinical outcomes in patients hospitalized with decompensated chronic liver disease: interim results from Global CLEARED study
30. Probiotics Do Not Alter Liver Function Markers and Clinical Parameters in Patients With Nonalcoholic Steatohepatitis and Low Degree of Fibrosis
31. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report
32. Capítulo 7 - Tratamiento de los genotipos 2 y 3 de la hepatitis C con esquemas libres de interferón
33. FRI014 - Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD score) on NAFLD in a mixed Latin American population
34. Anaphylaxis preceded by erythema multiforme with sorafenib: First case report
35. FRI-462-A multicenter international study of sorafenib treatment in patients with hepatocellular carcinoma and chronic kidney disease undergoing hemodialysis
36. Hand-grip strength or muscle mass in cirrhotic patients: Who is the best?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.